Demant A/S: Changes to Demant's Board of Directors
Company announcement no 2026-03 3 February 2026
Inside information
Changes to Demant’s Board of Directors
The Board intends to appoint Kristian Villumsen as new Chair of the Board
Thomas Hofman-Bang will be proposed for election to the Board at the upcoming annual general meeting
As previously announced, the current Chair of Demant’s Board of Directors, Niels B. Christiansen, has decided not to stand for re-election to the Board at the upcoming annual general meeting on 5 March 2026, after having served 17 years on the Board.
The Board will propose Thomas Hofman-Bang for election. He brings international leadership experience and a strong background from accounting and manufacturing companies. He serves on the boards of William Demant Foundation and William Demant Invest A/S, which will satisfy the Foundation charter requirement for representation on Demant’s Board.
After the annual general meeting, the Board intends to appoint Kristian Villumsen as new Chair. Kristian Villumsen is already a member of Demant’s Board, which he has been since 2021. He has deep insights into the healthcare industry and extensive international leadership experience from executive management and board positions.
“We will ensure continuity in Board leadership by appointing Kristian Villumsen as Chair. He brings strong listed-company leadership experience and extensive insight into Demant. We also welcome Thomas Hofman-Bang, who brings relevant experience that will support Demant going forward,” says Lars Nørby Johansen, Chair of the Board of Directors of William Demant Foundation, majority shareholder of Demant.
Kristian Villumsen, who is expected to become Chair of Demant’s Board of Directors, comments: “I look forward to leading Demant’s Board and supporting the company’s strategy and purpose of improving the lives of people with hearing loss.”
The other members of the Board elected at the annual general meeting, Niels Jacobsen, Sisse Fjelsted Rasmussen and Katrin Pucknat, will all stand for re-election. Niels Jacobsen will continue as Vice Chair, a role he has held since 2017. The Board of William Demant Foundation supports the proposals.
Kristian Villumsen currently holds the following positions:
- Evido ApS, chair
- UV Medico A/S, vice chair
Thomas Hofman-Bang currently holds the following positions:
- Industriens Fond, CEO
- William Demant Foundation, board member
- William Demant Invest A/S, board member
- Tryg A/S, board member and chair of the Audit and Risk Committees
- Fabriksejer, ingeniør Valdemar Selmer Trane og hustru, Elisa Tranes Fond, chair
- Fonden CBS Academic Housing, chair
- Foreningen Roskilde Festivalen, board member
The intention to appoint Kristian Villumsen new Chair of the Board is deemed inside information pursuant to Article 17 of the Market Abuse Regulation.
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 | Other contacts: René Schneider, CFO Peter Pudselykke, Head of Investor Relations Gustav Høegh, Investor Relations Officer Henrik Axel Lynge Buchter, Manager of External Communications |
Contacts
- Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 22,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.